TwinBeech Capital’s ResMed RMD Stock Holding History

TwinBeech Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,216	Closed	-$4.83M	–	853
2024 Q2	$4.83M	Buy	+25,216	New	+$5.12M	0.1%	234
2023 Q4	–	Sell	-105,333	Closed	-$15.6M	–	871
2023 Q3	$15.6M	Sell	105,333 -4,240	-4%	-$767K	0.3%	97
2023 Q2	$23.9M	Buy	109,573 +103,748	+1,781%	+$23.1M	0.47%	55
2023 Q1	$1.28M	Sell	5,825 -149,444	-96%	-$32.4M	0.03%	427
2022 Q4	$32.3M	Buy	+155,269	New	+$34.1M	0.61%	37
2022 Q3	–	Sell	-4,481	Closed	-$939K	–	784
2022 Q2	$939K	Sell	4,481 -10,975	-71%	-$2.34M	0.04%	334
2022 Q1	$3.75M	Sell	15,456 -31,702	-67%	-$7.67M	0.17%	169
2021 Q4	$12.3M	Buy	47,158 +27,625	+141%	+$7.17M	0.7%	33
2021 Q3	$5.15M	Buy	+19,533	New	+$5.34M	0.36%	72
2021 Q1	–	Sell	-15,577	Closed	-$3.31M	–	641
2020 Q4	$3.31M	Buy	+15,577	New	+$3.11M	0.54%	48

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

TwinBeech Capital's RMD Position: Q3 2024 in Review

TwinBeech Capital sold out of ResMed (RMD) in Q3 2024, closing a stake of 25,216 shares — an estimated $4.83M sold.

TwinBeech Capital first reported a position in RMD in Q4 2020 and held it in 10 quarters. The position peaked at $32.3M in Q4 2022. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

TwinBeech Capital reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
TwinBeech Capital sold 25,216 ResMed shares in Q3 2024, an estimated $4.83M.
TwinBeech Capital first reported a position in ResMed in Q4 2020 and held it in 10 quarters.
TwinBeech Capital's ResMed position peaked at $32.3M in Q4 2022.
801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on TwinBeech Capital's 13F filing for Q3 2024, filed 14 Nov 2024.